Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 428)
Posted On: 07/03/2025 6:57:19 PM
Post# of 154875
Posted By: mfglola
AstraZeneca contemplating a $15B licensing deal for Summit's Keytruda killer, ivonescimab. Hmmm.... makes you wonder how much Merck would pay us so they can combine leronlimab with Keytruda and fight off ivonescimab.

https://pharmaphorum.com/news/summit-climbs-r...a-interest













(12)
(0)








  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site